LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Castellvi Covers COVID’s Effect on Elective Surgery and Healthcare
Spine

Castellvi Covers COVID’s Effect on Elective Surgery and Healthcare

October 14, 2020 2 min read Premium comments

Advertisement

Castellvi Covers COVID’s Effect on Elective Surgery and Healthcare
Courtesy of FORE
Secondary#castellvispinemeeting#castellvi

The fourth, and final, session of the 2020 Castellvi Spine Conference was focused on the near- and long-term impacts of COVID-19 on spine and orthopedic practices, and healthcare as a whole. The session, held on October 1, began with a pair of industry talks from Baxter Advanced Surgery, and SI-BONE, Inc. Robert Norton, M.D. discussed Baxter’s perioperative blood management solutions, and Isador Lieberman, M.D., discussed his experience and the clinical evidence supporting the SI-BONE’s iFuse implants. Lieberman focused on the more recently cleared indication using the implants in the Bedrock™ procedure, which allows the triangular implant to be inserted alongside sacral-alar iliac screws to provide greater fixation of the sacroiliac joint.

Throughout the evening there were discussions that highlighted the different experiences between surgeons across the country. James Billys, M.D., from Odessa, Florida, moderated this final session. The panelists represented some Sunbelt states (Texas and Florida), and the East and West Coasts.

The CME talks began with Sigurd Berven, M.D., who is a surgeon at the University of California-San Francisco. He discussed the effects of COVID-19 on patients, surgeons, and the healthcare system. He discussed the rise of telemedicine, and that it still makes up a substantial portion of patient visits, still much higher than pre-pandemic rates.

Next, Alexander Vaccaro, M.D., discussed the impact of COVID-19 and restrictions on elective surgery at the Rothman Orthopaedic Institute, where he is a partner. He indicated the dire straits the organization was in as the pandemic intensified. With elective surgeries severely limited in the areas that the group operates (Pennsylvania, New York, and New Jersey) most orthopedic surgeons had no cases, generated no revenue, and looked on enviously as the spine surgeons performed more urgent cases that were still allowed. As the case counts increased in the North East, the unlikelihood of returning to normalcy became much more apparent, leading the organization to furlough substantial portions of its surgeons and staff. Partners also took extreme pay cuts to keep the group afloat. The experience was similar in other regions where the pandemic hit most severely.

Finally, Stephen Hochschuler, M.D., a surgeon at Texas Back Institute (TBI), located in the Dallas, Texas area, discussed his different experience. Unlike the North East, Texas resumed elective surgeries early in the pandemic. With expanded telemedicine options, careful adherence to COVID protocols, and favorable governmental policies, the surgeons at TBI, were minimally affected, especially compared to those at Rothman.

The discussion touched on a few politically sensitive areas, namely whether or not a single-payer system would have helped or hindered the progression of the pandemic and individual’s ability to seek help.

The robust discussion was a fitting end to the last session of the Castellvi Spine Conference. All of the panelists shared similar feelings about their optimism and excitement to attend the 2021 meeting, currently scheduled for early May.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy